Your browser doesn't support javascript.
loading
17p12 Influences Hematoma Volume and Outcome in Spontaneous Intracerebral Hemorrhage.
Marini, Sandro; Devan, William J; Radmanesh, Farid; Miyares, Laura; Poterba, Timothy; Hansen, Björn M; Norrving, Bo; Jimenez-Conde, Jordi; Giralt-Steinhauer, Eva; Elosua, Roberto; Cuadrado-Godia, Elisa; Soriano, Carolina; Roquer, Jaume; Kourkoulis, Christina E; Ayres, Alison M; Schwab, Kristin; Tirschwell, David L; Selim, Magdy; Brown, Devin L; Silliman, Scott L; Worrall, Bradford B; Meschia, James F; Kidwell, Chelsea S; Montaner, Joan; Fernandez-Cadenas, Israel; Delgado, Pilar; Greenberg, Steven M; Lindgren, Arne; Matouk, Charles; Sheth, Kevin N; Woo, Daniel; Anderson, Christopher D; Rosand, Jonathan; Falcone, Guido J.
Afiliação
  • Marini S; From the Center for Genomic Medicine (S.M., W.J.D., F.R., C.E.K., C.D.A., J.R.).
  • Devan WJ; From the Center for Genomic Medicine (S.M., W.J.D., F.R., C.E.K., C.D.A., J.R.).
  • Radmanesh F; From the Center for Genomic Medicine (S.M., W.J.D., F.R., C.E.K., C.D.A., J.R.).
  • Miyares L; Massachusetts General Hospital, Boston; Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale University School of Medicine, New Haven, CT (L.M., C.M., K.N.S., G.J.F.).
  • Poterba T; Analytic and Translational Genetics Unit (T.P.).
  • Hansen BM; Department of Neurology and Rehabilitation, Skåne University Hospital, Lund, Sweden (B.M.H., B.N., A.L.).
  • Norrving B; Department of Clinical Sciences Lund, Neurology, Lund University, Sweden (B.M.H., B.N., A.L.).
  • Jimenez-Conde J; Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden (B.M.H., B.N., A.L.).
  • Giralt-Steinhauer E; Department of Neurology and Rehabilitation, Skåne University Hospital, Lund, Sweden (B.M.H., B.N., A.L.).
  • Elosua R; Department of Clinical Sciences Lund, Neurology, Lund University, Sweden (B.M.H., B.N., A.L.).
  • Cuadrado-Godia E; Department of Neurology and Rehabilitation Medicine, Skåne University Hospital, Lund, Sweden (B.M.H., B.N., A.L.).
  • Soriano C; Department of Neurology, Hospital del Mar Medical Research Institute (IMIM) (J.J.-C., E.G.-S., R.E., E.C.-G., C.S., J.R.).
  • Roquer J; Department of Neurology, Hospital del Mar Medical Research Institute (IMIM) (J.J.-C., E.G.-S., R.E., E.C.-G., C.S., J.R.).
  • Kourkoulis CE; Department of Neurology, Hospital del Mar Medical Research Institute (IMIM) (J.J.-C., E.G.-S., R.E., E.C.-G., C.S., J.R.).
  • Ayres AM; Department of Neurology, Hospital del Mar Medical Research Institute (IMIM) (J.J.-C., E.G.-S., R.E., E.C.-G., C.S., J.R.).
  • Schwab K; Department of Neurology, Hospital del Mar Medical Research Institute (IMIM) (J.J.-C., E.G.-S., R.E., E.C.-G., C.S., J.R.).
  • Tirschwell DL; Department of Neurology, Hospital del Mar Medical Research Institute (IMIM) (J.J.-C., E.G.-S., R.E., E.C.-G., C.S., J.R.).
  • Selim M; From the Center for Genomic Medicine (S.M., W.J.D., F.R., C.E.K., C.D.A., J.R.).
  • Brown DL; Universitat Autónoma de Barcelona, Spain; Department of Neurology, J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA (A.M.A., K.S., S.M.G.).
  • Silliman SL; Universitat Autónoma de Barcelona, Spain; Department of Neurology, J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA (A.M.A., K.S., S.M.G.).
  • Worrall BB; Stroke Center, Harborview Medical Center, University of Washington, Seattle (D.L.T.).
  • Meschia JF; Stroke Division, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA (M.S.).
  • Kidwell CS; Stroke Program, Department of Neurology, University of Michigan, Ann Arbor (D.L.B.).
  • Montaner J; Department of Neurology, University of Florida College of Medicine, Jacksonville (S.L.S.).
  • Fernandez-Cadenas I; Department of Neurology and Public Health Sciences, University of Virginia Health System, Charlottesville (B.B.W.).
  • Delgado P; Department of Neurology, Mayo Clinic, Jacksonville, FL (J.F.M.).
  • Greenberg SM; Department of Neurology, University of Arizona, Tucson (C.S.K.).
  • Lindgren A; Neurovascular Research Laboratory and Neurovascular Unit, Institut de Recerca, Hospital Vall d'Hebron (J.M., I.F.-C., P.D.).
  • Matouk C; Neurovascular Research Laboratory and Neurovascular Unit, Institut de Recerca, Hospital Vall d'Hebron (J.M., I.F.-C., P.D.).
  • Sheth KN; Stroke Pharmacogenomics and Genetics Sant Pau Institute of Research, Barcelona, Spain (I.F.-C.).
  • Woo D; Neurovascular Research Laboratory and Neurovascular Unit, Institut de Recerca, Hospital Vall d'Hebron (J.M., I.F.-C., P.D.).
  • Anderson CD; Universitat Autónoma de Barcelona, Spain; Department of Neurology, J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA (A.M.A., K.S., S.M.G.).
  • Rosand J; Department of Neurology and Rehabilitation, Skåne University Hospital, Lund, Sweden (B.M.H., B.N., A.L.).
  • Falcone GJ; Department of Clinical Sciences Lund, Neurology, Lund University, Sweden (B.M.H., B.N., A.L.).
Stroke ; 49(7): 1618-1625, 2018 07.
Article em En | MEDLINE | ID: mdl-29915124
BACKGROUND AND PURPOSE: Hematoma volume is an important determinant of clinical outcome in spontaneous intracerebral hemorrhage (ICH). We performed a genome-wide association study (GWAS) of hematoma volume with the aim of identifying novel biological pathways involved in the pathophysiology of primary brain injury in ICH. METHODS: We conducted a 2-stage (discovery and replication) case-only genome-wide association study in patients with ICH of European ancestry. We utilized the admission head computed tomography to calculate hematoma volume via semiautomated computer-assisted technique. After quality control and imputation, 7 million genetic variants were available for association testing with ICH volume, which was performed separately in lobar and nonlobar ICH cases using linear regression. Signals with P<5×10-8 were pursued in replication and tested for association with admission Glasgow coma scale and 3-month post-ICH dichotomized (0-2 versus 3-6) modified Rankin Scale using ordinal and logistic regression, respectively. RESULTS: The discovery phase included 394 ICH cases (228 lobar and 166 nonlobar) and identified 2 susceptibility loci: a genomic region on 22q13 encompassing PARVB (top single-nucleotide polymorphism rs9614326: ß, 1.84; SE, 0.32; P=4.4×10-8) for lobar ICH volume and an intergenic region overlying numerous copy number variants on 17p12 (top single-nucleotide polymorphism rs11655160: ß, 0.95; SE, 0.17; P=4.3×10-8) for nonlobar ICH volume. The replication included 240 ICH cases (71 lobar and 169 nonlobar) and corroborated the association for 17p12 (P=0.04; meta-analysis P=2.5×10-9; heterogeneity, P=0.16) but not for 22q13 (P=0.49). In multivariable analysis, rs11655160 was also associated with lower admission Glasgow coma scale (odds ratio, 0.17; P=0.004) and increased risk of poor 3-month modified Rankin Scale (odds ratio, 1.94; P=0.045). CONCLUSIONS: We identified 17p12 as a novel susceptibility risk locus for hematoma volume, clinical severity, and functional outcome in nonlobar ICH. Replication in other ethnicities and follow-up translational studies are needed to elucidate the mechanism mediating the observed association.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 17 / Hemorragia Cerebral / Hematoma Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Stroke Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Cromossomos Humanos Par 17 / Hemorragia Cerebral / Hematoma Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Stroke Ano de publicação: 2018 Tipo de documento: Article